Rubinstein E - Search Results

1

Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group.

Rubinstein E, Lode H, Grassi C. Rubinstein E, et al. Clin Infect Dis. 1995 May;20(5):1217-28. doi: 10.1093/clinids/20.5.1217. Clin Infect Dis. 1995. PMID: 7620002 Clinical Trial.

2

Double-blind randomized study of 1 g versus 2 g intravenous ceftriaxone daily in the therapy of community-acquired infections.

Segev S, Raz R, Rubinstein E, Shmuely H, Hassin D, Rosen N, Platau E, Ben Assuli S, Pitlik S. Segev S, et al. Among authors: rubinstein e. Eur J Clin Microbiol Infect Dis. 1995 Oct;14(10):851-5. doi: 10.1007/BF01691490. Eur J Clin Microbiol Infect Dis. 1995. PMID: 8605897 Clinical Trial.

3

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.

Rubinstein E, Cammarata S, Oliphant T, Wunderink R; Linezolid Nosocomial Pneumonia Study Group. Rubinstein E, et al. Clin Infect Dis. 2001 Feb 1;32(3):402-12. doi: 10.1086/318486. Epub 2001 Jan 26. Clin Infect Dis. 2001. PMID: 11170948 Clinical Trial.

4

Pefloxacin versus ceftazidime in therapy of soft tissue infections in compromised patients.

Segev S, Rosen N, Pitlik SD, Block C, Rubinstein E. Segev S, et al. Among authors: rubinstein e. J Antimicrob Chemother. 1990 Oct;26 Suppl B:193-8. doi: 10.1093/jac/26.suppl_b.193. J Antimicrob Chemother. 1990. PMID: 2258349 Clinical Trial.

5

Pefloxacin treatment of meningitis caused by gram-negative bacteria.

Segev S, Barzilai A, Rosen N, Joseph G, Rubinstein E. Segev S, et al. Among authors: rubinstein e. Arch Intern Med. 1989 Jun;149(6):1314-6. Arch Intern Med. 1989. PMID: 2730249

6

The effect of albumin, globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.

Rubinstein E, Diamantstein L, Yoseph G, Gruzman G, Rubinovitch B, Barzilai A, Keller N. Rubinstein E, et al. Clin Microbiol Infect. 2000 Dec;6(12):678-81. doi: 10.1046/j.1469-0691.2000.00166.x. Clin Microbiol Infect. 2000. PMID: 11284929 Free article. No abstract available.

7

Ceftizoxime vs. cefotaxime--a comparative randomized multicenter study.

Segev S, Kitzes R, Rubinstein E, Pitlik S, Samra Y, Shenkman L, Weinberg M. Segev S, et al. Among authors: rubinstein e. Isr J Med Sci. 1988 Aug;24(8):410-4. Isr J Med Sci. 1988. PMID: 3045049 Clinical Trial.

8

Transepithelial intestinal excretion of ciprofloxacin in humans.

Ramon J, Ben-Haim M, Shabtai M, Rubinstein E. Ramon J, et al. Among authors: rubinstein e. Clin Infect Dis. 2001 Mar 1;32(5):822-3. doi: 10.1086/319206. Epub 2001 Feb 19. Clin Infect Dis. 2001. PMID: 11229852

9

Pefloxacin efficacy in gram-negative bacillary meningitis.

Segev S, Rosen N, Joseph G, Elran HA, Rubinstein E. Segev S, et al. Among authors: rubinstein e. J Antimicrob Chemother. 1990 Oct;26 Suppl B:187-92. doi: 10.1093/jac/26.suppl_b.187. J Antimicrob Chemother. 1990. PMID: 2258348

10

Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice.

Ofek I, Cohen S, Rahmani R, Kabha K, Tamarkin D, Herzig Y, Rubinstein E. Ofek I, et al. Among authors: rubinstein e. Antimicrob Agents Chemother. 1994 Feb;38(2):374-7. doi: 10.1128/AAC.38.2.374. Antimicrob Agents Chemother. 1994. PMID: 8192470 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

777 results

Search Page

Filters